Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Adjustments and Eliminations	-423.58M	-603.39M	-1.38B	-444.36M	-201.07M
Medical Devices and Medical Diagnosis	4.35B	4.44B	7.25B	5.97B	5.29B
Medical Devices and Medical Diagnosis Growth	-2.07%	-38.74%	21.44%	12.91%	40.01%
Others	191.70M	151.06M	156.25M	81.80M	93.91M
Others Growth	26.91%	-3.33%	91.03%	-12.90%	-5.95%
Pharmaceutical Manufacturing	29.27B	30.69B	31.77B	29.21B	21.94B
Pharmaceutical Manufacturing Growth	-4.62%	-3.38%	8.75%	33.14%	0.74%
Medical and Health Services	7.67B	6.71B	6.16B	4.19B	3.18B
Medical and Health Services Growth	14.28%	9.04%	47.02%	31.59%	4.55%
Total	41.07B	41.40B	43.95B	39.01B	30.31B
Total Growth	-0.80%	-5.81%	12.66%	28.72%	6.02%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Mainland China	29.77B	31.03B	30.01B	25.41B	22.12B
Mainland China Growth	-4.06%	3.38%	18.11%	14.89%	0.71%
Other Countries or Regions	11.30B	10.37B	13.94B	13.60B	8.19B
Other Countries or Regions Growth	8.94%	-25.60%	2.49%	66.08%	23.66%
Total	41.07B	41.40B	43.95B	39.01B	30.31B
Total Growth	-0.80%	-5.81%	12.66%	28.72%	6.02%

Source: S&P Global Market Intelligence.